Resumen
El ventrículo derecho es susceptible a cambios en la precarga, poscarga y la contractilidad y la respuesta fisiopatológica es la dilatación con disfunción/falla aguda lo que limita el llenado del ventrículo izquierdo y el gasto cardiaco. La congestión venosa sistémica, está implicada en la génesis del choque cardiogénico con compromiso del ventrículo derecho. Esta forma de choque es menos conocida que la que sucede por falla ventricular izquierda, por ende, el tratamiento puede diferir. La primera línea de tratamiento son las medidas de soporte y en caso de no funcionar, el tratamiento dirigido a la fisiopatología ventricular será la siguiente opción. Se sugiere evaluar la precarga para la indicación razonada de líquidos, diuréticos o la ultrafiltración. Restaurar o mantener la frecuencia cardiaca y el ritmo sinusal, tratar la bradicardia sintomática, las arritmias que inestabilizan a los pacientes, el uso de marcapaso temporal o procedimientos de cardioversión. Mejorar la contractilidad y vasomotilidad a través del uso de vasopresores e inotrópicos, solos o combinados, el objetivo será mejorar la presión de perfusión coronaria derecha. Balancear el efecto de fármacos y maniobras en la precarga y/o poscarga, como la ventilación mecánica, septostomía atrial y vasodilatadores pulmonares. Y la creciente utilidad del soporte mecánico de la circulación que se ha convertido en una herramienta útil para preservar/restaurar la función cardiaca derecha.
Abstract
The right ventricle is susceptible to changes in preload, afterload, and contractility. The answer is its dilation with dysfunction/acute failure; filling is limited to the left ventricle and cardiac output. Systemic venous congestion is retrograde to the right heart, it is involved in the genesis of cardiogenic shock due to right ventricle involvement. This form of shock is less well known than that which occurs due to left ventricular failure, therefore, treatment may differ. Once the primary treatment has been carried out, since no response is obtained, supportive treatment aimed at ventricular pathophysiology will be the next option. It is suggested to evaluate the preload for the reasoned indication of liquids, diuretics or even ultrafiltration. Restore or maintain heart rate and sinus rhythm, treat symptomatic bradycardia, arrhythmias that make patients unstable, use of temporary pacing or cardioversion procedures. Improving contractility and vasomotility, using vasopressors and inotropes, alone or in combination, the objective will be to improve right coronary perfusion pressure. Balance the effect of drugs and maneuvers on preload and/or afterload, such as mechanical ventilation, atrial septostomy and pulmonary vasodilators. And the increasing utility of mechanical support of the circulation that has become a useful tool to preserve/restore right heart function.
Kanwar MK, Everett KD, Gulaati G, Brener MI, Kapur NK. Epidemiology and management of right ventricular- predominant heart failure and shock in the cardiac intensive care unit. Eur Hearth J. 2022:00; 1-11. doi:10.1093/ehjacc/zuac063.
Zhao S, Friedman O. Management of right ventricular failure in pulmonary embolism. Crit Care Clin. 2020;36(3):505-15. doi:10.1016/j.ccc.2020.02.006.
Nägele MP, Flammer AJ. Heart failure after right ventricular myocardial infarction. Curr Heart Fail Rep. 2022;19(6);375-85. doi.10.1007/s11897-022-00577-8.
Femia G, French JK, Juergens C, Leung D, Lo S. Right ven[1]tricular infarction: pathophysiology, clinical implications and management. Rev Cardiovasc Med. 2021;22(4):1229-40. doi:10.31083/j.rcm2204131.
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.
Albulushi A, Giannopoulos A, Kafkas N, Dragasis S, Pavlides G, Chatzizisis YS. Acute right ventricular infarction. Expert Rev CardiovascTher. 2018;16(7):455-64. doi:10.1080/147790 72.2018.1489234.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39 (2):119-77. doi: 10.1093/eurheartj/ehx393.
Bertini P, Guarracino F. Pathophysiology of cardiogenic shock. Curr Opin Crit Care. 2021;27(4):409-15. doi. 10.1097/ MCC.0000000000000853.
Ismail MT, El-Iraky AA, Ibrahim EEA, El-Kammash TH, Abou-Zied AE. Comparison of inferior vena cava collapsibility and central venous pressure in assessing volume status in shocked patients. Afr J Emerg Med. 2022; 12(3); 165-71.
Grignola JC, Domingo E. Acute right ventricular dysfunction in intensive care unit. Biomed Res Int. 2017; 2017:8217105. doi: 10.1155/2017/8217105.
Verbrugge FH, Guazzi M, Testani JM, Bourlaug BA. Altered hemodynamics and end-organ damage in heart failure: Impacto n the lung and kidney. Circulation. 2020;142(10): 998- 1012. doi:10.1161/CIRCULATION AHA.119.045409.
Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, et al. The use of diuretics in heart failure with congestion a position statement from the Heart Failure Association of the European Society of cardiology. Eur J Heart Fail. 2019;21(2):137-55. doi: 10.1002/ejhf.1369.
Arrigo M, Huber LCh, Winnik S, Mikulicic F, Guidetti F, Frank M, et al. Right ventricular failure: Pathophysiology, diagnosis and treatment. Cardiac Failure Reviews. 2019;5(3): 140-6. Doi.org/10.15420/cfr.2019.15.2.
Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, Ewalenko P, et al. Effects of norepinephrine and dobutamine on pressure load- induced right ventricular failure. Crit Care Med. 2004;32(4):1035-40. doi: 10.1097//01.CCM. 0000120052.77953.07.
Zhang H, Jiang L, Fu R, Qin P, Zhang X, Tian T, et al. Impact of levosimendán on efficacy and renal function in acute heart failure according to renal function: A perspective, multi-center, real-world registry. Front Cardiovasc Med. 2022; 9:986039. doi: 10.3389/fcvm.2022.986039.
Johannes J, Berlin DA, Patel P, Schenck EJ, West FM, Saggar R, et al. A technique of awake bronchoscopic endotracheal intubation for respiratory failure in patients with right heart failure and pulmonary hypertension. Crit Care Med. 2017;45(9): e980-4. doi: 10.1097/CCM.0000000000002586.
Tavazi G. Mechanical ventilation in cardiogenic shock. Curr Opin Crit Care. 2021;27(4):447-53. doi:10.1097/MCC. 0000000000000836.
Zochios V, Parthar K, Vieillard-Baron A. Protecting the right ventricle in ARDS: The role of prone ventilation. Intensive Care Med. 2018;32(5):2248-51. doi.org/10.1053/j.jvca.2018.01.007.
Sandoval J. The long and winding road of atrial septostomy. Diagnostics (Basel). 2020;10(11):971. Doi: 10.3390/ diagnostics10110971.
Santos-Martinez LE, Baranda-Tovar FM, Telona-Fermán E, Barragán-García R, Calderon-Abbo MC. Iloprost inhalado, un vasodilatador pulmonar selectivo. Evidencia clínica de su uso en el perioperatorio de cirugía cardiovascular e hipertensión pulmonar. Arch Cardiol Mex. 2015; 85(2)136-44. doi: 10.1016/j.acmx.2014.01.003.
Santos-Martínez LE, Moreno-Ruiz LA, Cabrera-Ramírez C, Mendoza-Pérez C, Galván-Oseguera H, Magaña-Serrano JA, et al. Hipertensión arterial pulmonar desde la evaluación del riesgo al tratamiento combinado. Rev Med Inst Mex Seguro Soc. 2019;57(5)314-23.
Josiassen J, Helgestad OKL, Møller JE, et al. Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021;10(1):33-39. Doi:10.1093/ehjacc/zuaa010.
Lusebrink E, Binzenhofer L, Kellnar A, Muller C, Scherer C, Schrage B, et al. Venting during venoarterial extracorporeal membrane oxygenation. Clin Res Cardiol. 2022. doi:10.1007/ s00392-022-02069-0.
Grant Ch, Richards JB, Frakes M, Cohen J, Wilcox SR. ECMO and right ventricular failure: Review of the literature. J Intensiv Care Med. 2021; 36(3): 352-60. doi: 10.1177/ 0885066619900503.
DeFilippis EM, Topkara VK, Kirtane AJ, Takeda K, Naka Y, Garan AR. Mechanical circulatory support for right ventricular failure. Card Fail Rev. 2022;8: e14. doi:10.15420/cfr.2021.11.
Geller BJ, Sinha SS, Kapur NK, Bakitas M, Balsam LB, Chikwe J, et al. Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: A scientific statement from the American Heart Association. Circulation. 2022; 146:00-00. doi: 10.1161/CIR.0000000000001076.
Ma M, Liang S, Zhu J, Dai M, Jia Z, Huang H, et al. The efficacy and safety of bivalirudin versus heparin in the anticoagulation therapy of extracorporeal membrane oxygenation: A systematic review and meta-analysis. Front Pharmacol. 2022;22(13): 771563. doi: 10.3389/fphar.2022.771563.